PROVIDER PROFILE · NPI 1679540363

Mikael LagwinskiMD

RheumatologyMeridian, IDI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

4,465

Unique beneficiaries

—

Total services

114,471

Distinct HCPCS

Medicare payment

$2.2M

Peer benchmark

Total Medicare services vs. 21 Rheumatology providers in ID — top quintile (cohort median 646).

PRESCRIBING · PART D · 2024

Total Rx claims

4,346

Beneficiaries

—

Total drug cost

$2.2M

Distinct drugs

Brand share

28.1%

Top prescribed drugs

Hydroxychloroquine Sulfate1,138 claims

Methotrexate Sodium834 claims

Prednisone571 claims

Leflunomide335 claims

Sulfasalazine303 claims

QUALITY · MIPS · 2024

Final MIPS score

91.0

Quality

100.0

Cost

70.1

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.67%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$17

Payment records

By payment type

Food and Beverage$17

REFERRAL NETWORK

Where Mikael Lagwinski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Seattle, WA	110	323
Steven Marx Diagnostic Radiology · Boise, ID	12	19
James Hill Diagnostic Radiology · Boise, ID	12	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history